Pharmaceuticals & Biotechnology Editor | 09/14/2011
Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening resu...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More